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Perspective
W
omen addicted to cocaine 
often continue drug use 
through pregnancy, despite 
risks to the fetuses they are carrying. 
Multiple studies have attempted to 
identify the effects of cocaine and other 
commonly abused drugs on fetal brain 
development and behavior in clinical 
populations. The attribution of risk 
to speciﬁc drugs remains challenging, 
however, because women addicted to 
cocaine often use other illegal drugs as 
well as alcohol and tobacco. Moreover, 
they tend to have poor nutrition, 
low levels of prenatal care, and other 
problems that confound analysis. 
Not surprisingly, as the outcomes of 
different cohorts of pregnant women 
who use drugs are examined, diverse 
ﬁndings have been reported. Overall, 
however, children exposed to cocaine 
prenatally appear to have neurological 
and cognitive deﬁcits. For example, at 
six months of age children exposed to 
cocaine in utero have been observed to 
have abnormalities of tone and posture 
[1]. A longitudinal, prospective, 
comparison birth cohort study that 
measured drug levels in urine and 
meconium found that children 
exposed to cocaine showed signiﬁcant 
cognitive deﬁcits and a higher rate of 
developmental delay during the ﬁrst 
two years of life [2]. Another cohort 
of children exposed to cocaine and 
other drugs had deﬁcits in sustained 
attention and problems with impulsivity 
at age four [3]. 
Animal and Cellular Models of 
Prenatal Cocaine Exposure
Animal and cell culture models have 
been widely used to investigate effects 
of cocaine and the mechanisms 
by which it might act during brain 
development. In this issue of PLoS 
Medicine, Chun-Ting Lee and 
colleagues use both cell culture 
and fetal rat models to investigate 
mechanisms by which cocaine might 
decrease the number of neurons in the 
brain [4].
Animal models have the advantage 
of permitting the study of individual 
drugs such as cocaine with far fewer 
confounding variables than those 
that bedevil human studies. Animal 
models also allow for well-controlled 
behavioral studies in the laboratory [5] 
and invasive anatomic, physiological, 
and biochemical studies [6,7]. Studies 
of cocaine effects in tissue culture 
facilitate well-controlled investigations 
of molecular mechanisms of drug 
action, especially mechanisms that 
are cell-autonomous. The brain is 
characterized by complex interactions 
of neural circuits and multiple 
neurotransmitters. In the mature 
brain, cocaine inhibits the uptake 
of dopamine, norepinephrine, 
and serotonin by their respective 
transporters, thus increasing synaptic 
levels of these neurotransmitters. 
Despite the limitations of cell culture—
it is difﬁcult to recreate the cellular and 
chemical environment of the brain—
Lee and colleagues used cell culture to 
examine neurotransmitter-independent 
actions of cocaine on a neuronal 
precursor cell line, AF5, and on human 
primary neural progenitors [4]. 
Mechanism by Which Cocaine 
Inhibits Cell Proliferation
Primate studies have shown that 
intrauterine cocaine exposure (during 
a period corresponding to the second 
trimester in humans) results in a 
decrease in the number of neurons in 
the cerebral cortex and disorganization 
of the normal laminar structure of the 
cortex [6,7]. Based on such ﬁndings, 
Lee and colleagues investigated 
mechanisms by which cocaine might 
inhibit the proliferation of neural 
progenitor cells. Of course, decreased 
cell number might also result from 
cell death, but based on evidence 
that cocaine can inhibit proliferation 
without killing neurons [8], Lee and 
colleagues focused on nonlethal actions 
of cocaine on neurons [4]. It should 
be acknowledged, however, that in 
noncortical regions, such as the locus 
coeruleus of the brainstem, cocaine has 
been reported to produce apoptosis 
[9]. 
In an impressive series of 
experiments, the researchers showed 
that cocaine inhibits cell proliferation 
without affecting cell survival in AF5 
cells, and does so in the absence 
of dopamine, norepinephrine, or 
serotonin. This antiproliferative effect 
occurs by blocking the cell cycle, 
speciﬁcally the G1/S phase transition 
beyond which cells are committed to 
division. Using microarray technology, 
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the researchers found that of the 
93 cell cycle genes they examined, 
only cyclin A2 was signiﬁcantly down-
regulated by cocaine. They then 
showed that cocaine also suppressed 
cyclin A2 in primary human fetal cells 
(largely neuronal by their markers), 
derived from the cerebral cortices of 
second-trimester human fetuses, and 
also in fetal rat brains during early 
(embryonic day 13–15) or middle 
(embryonic day 15–17) periods of 
neurogenesis. 
Cocaine appears to cause down-
regulation of cyclin A2 by generating 
reactive oxygen species, which in turn 
causes an endoplasmic reticulum stress 
response. The generation of reactive 
oxygen species depends on N-oxidation 
of cocaine by cytochrome P450. This 
led the investigators to test cytochrome 
P450 inhibitors, including the widely 
available drug cimetidine (originally 
developed as a histamine H2 receptor 
antagonist to treat peptic ulcers), in 
both AF5 cells and in cocaine-exposed 
fetal rats. In cell culture, the P450 
inhibitors SKF-525A and cimetidine 
blocked cocaine-induced formation 
of reactive oxygen species and 
signiﬁcantly diminished the inhibitory 
effects of cocaine on cell proliferation. 
When pregnant rats were pretreated 
with cimetidine prior to each cocaine 
administration, the effects of cocaine 
on cyclin A2 down-regulation and on 
the inhibition of cell proliferation were 
signiﬁcantly blocked.
Clinical Implications
Both animal and cell culture studies 
trade control of variables and the 
opportunity for invasive analysis for 
questions about “real world” relevance 
in humans. Two critical questions 
in examining the developmental 
effects of an environmental toxin 
such as cocaine, whether in humans 
or in animal models, are the dose 
and route of administration and the 
timing of the exposure. Even brief 
exposure at a particularly vulnerable 
time in brain development may have 
lasting deleterious effects of greater 
magnitude than greater exposures 
at other times [10]. Moreover, the 
postnatal age at which the effects of 
cocaine are measured, whether in 
humans or animals, may show evolving 
outcomes. In humans, the attribution 
of outcomes to drug effect is 
complicated by the observation that the 
circumstances under which children 
have been raised subsequent to cocaine 
exposure affect their behavior [11]. 
An important strength of this study 
was the use of cocaine concentrations 
in both animal and cell culture 
experiments that are likely to correlate 
with those found in human fetal brains. 
Its most important strength was that 
it examined a possible mechanism 
by which cocaine might suppress the 
proliferation of neurons and used 
this mechanistic analysis to identify a 
drug that might block this deleterious 
effect. It will be a challenging matter 
of further research to determine 
whether the inhibition of proliferation 
is relevant to the human situation and 
whether this research provides ideas 
about preventive interventions for 
those pregnant women who cannot 
abstain from cocaine. This early 
research is exciting, but the reader 
must keep in mind the complexity 
of factors that might contribute to 
cognitive and emotional abnormalities 
in children exposed to cocaine and 
other dangerous drugs in utero.  
References
1.  Chiriboga CA, Kuhn L, Wasserman GA (2007) 
Prenatal cocaine exposures and dose-related 
cocaine effects on infant tone and behavior. 
Neurotoxicol Teratol 29: 323-330.
2.  Singer LT, Arendt R, Minnes S, Farkas K, 
Salvator A, et al. (2002) Cognitive and motor 
outcomes of cocaine-exposed infants. JAMA 
287: 1952-1960.
3.  Noland JS, Singer LT, Short EJ, Minnes 
S, Arendt RE, et al. (2005) Prenatal 
drug exposure and selective attention in 
preschoolers. Neurotoxicol Teratol 27: 429-438.
4.  Lee C-T, Chen J, Hayashi T, Tsai S-Y, Sanchez 
JF, et al. (2008) A mechanism responsible 
for the inhibition of neural progenitor cell 
proliferation by cocaine. PLoS Med 5: e117. 
doi:10.1371/journal.pmed.0050117
5.  Malanga CJ, Pejchal M, Kosofsky BE (2007) 
Prenatal exposure to cocaine alters the 
development of conditioned place-preference 
to cocaine in adult mice. Pharmacol Biochem 
Behav 87: 462-471.
6.  Lidow MS, Song ZM (2001) Primates exposed 
to cocaine in utero display reduced density and 
number of cerebral cortical neurons. J Comp 
Neurol 435: 263-275.
7.  Lidow MS, Song ZM. (2001) Effect of cocaine 
on cell proliferation in the cerebral wall of 
monkey fetuses. Cereb Cortex 11: 545-551.
8.  Hu S, Cheeran MC, Sheng WS, Ni HT, 
Lokensgard JR, et al. (2006) Cocaine alters 
proliferation, migration, and differentiation 
of human fetal brain-derived neural precursor 
cells. J Pharmacol Exp Ther 318: 1280-1286.
9.  Dey S, Snow DM (2007) Cocaine exposure in 
vitro induces apoptosis in fetal locus coeruleus 
neurons through TNF-alpha-mediated induction 
of Bax and phosphorylated c-Jun NH(2)-
terminal kinase. J Neurochem 103: 542-556.
10. Kosofsky BE, Hyman SE (2001) No time for 
complacency: The fetal brain on drugs. J Comp 
Neurol 435: 259-262.
11. Frank DA, Augustyn M, Knight WG, Pell T, 
Zuckerman B (2001) Growth, development, 
and behavior in early childhood following 
prenatal cocaine exposure: A systematic review. 
JAMA 285: 1613-1625.